ICMR-NIV Pune inaugurates High Performance Computing facility to boost genomic research and pandemic preparedness
High Performance Computing
(HPC) facility at the ICMR-National Institute of Virology (NIV), Pune.
The computing cluster named 'Nakshatra' was officially inaugurated by Dr Rajiv Bahl, Secretary of the Department of Health Research (DHR) and Director General of ICMR, according to an official statement from ICMR.
"Developed under the Pradhan Mantri Ayushman Bharat Health Infrastructure Mission (PM ABHIM), the HPC facility forms the cornerstone of a new project titled "High Performance Computing
Next Generation Sequencing
(NGS) Hub".
The initiative aims to revolutionize how genomic and
bioinformatics
data are processed, addressing limitations faced during the COVID-19 pandemic due to conventional computing infrastructure," the statement added.
Addressing a gathering regarding the inauguration of the computing facility, the Director General of ICMR commended the institute for its timely and strategic step towards '
Viksit Bharat 2047
' vision by strengthening the country's genomic surveillance and data analysis capacity.
He highlighted how enhanced computing resources are crucial in preparing for technology-driven
pandemic preparedness
and future public health emergencies.
Meanwhile, Director of ICMR-NIV, Dr Naveen Kumar, emphasised the critical role the HPC cluster will play in supporting rapid, data-driven responses to outbreaks. Dr Sarah Cherian, Group Leader of the Bioinformatics and Data Management Group and Principal Investigator of the project, provided a comprehensive overview of the cluster's capabilities and its role in
genomic research
.
According to the official statement, the newly commissioned HPC cluster features twelve compute nodes offering a total of 700 cores and 1 petabyte of storage.
"The infrastructure is tailored to support complex bioinformatics workflows, including next-generation sequencing (NGS), transcriptomics, phylogenetics, metagenomics, and structural bioinformatics.
Initially, the facility will serve five ICMR institutes across the country, acting as a central repository for sequencing data and extending support to Viral Research and Diagnostic Laboratories (VRDLs) soon, making the institute as a critical hub for outbreak investigations and pandemic preparedness, with the potential to accelerate AI-driven drug and vaccine discovery," the statement added.
Highlighting the advantages of the HPC facility, ICMR highlighted how it is a "national investment in speed, precision, and preparedness."
The statement mentioned, "By enabling faster analysis of complex genomic data, the facility positions India to detect new disease threats sooner, respond to outbreaks more efficiently, and accelerate AI-driven vaccine and drug development."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fashion Value Chain
10 hours ago
- Fashion Value Chain
Fortis Hospitals Mumbai Launches Citywide Campaign for Brain Health Awareness on World Brain Day
On the occasion of World Brain Day 2025, Fortis Hospitals Mumbai launched a unique citywide awareness campaign titled 'Helmet Pehna Kya', in an attempt to spark public dialogue around the importance of brain health and proactive care. The campaign, saw more than fifty volunteers walk the streets of Mumbai wearing helmets in unexpected places. Fortis Mumbais Helmet Pehna Kya sqad all set to engage Mumbaikars on World Brain Day 2025 Volunteers wearing helmets attracted attention and struck up conversations everywhere from local trains and flower markets to office parks and roadside food stands, leading Mumbaikars to wonder, 'Why are they wearing the helmet here'The answer To emphasize a crucial point: your brain should be protected every day, not only in the event of an accident. Fortis Hospitals Mumbai questioned common belief that brain safety is solely related to accident-related trauma by introducing a symbol of physical protection (the helmet) in routine, low or no-risk situations. Instead, the campaign reframed helmets as a symbol of routine checkups, mental wellness, early detection, and lifestyle modification. The initiative aims to remind people that brain health is a daily priority rather than an emergency, this innovative activation not only attracted Mumbaikars attention but also struck the relevant conversations. This initiative couldn't be timed better. Across India, neurological disorders are becoming an everyday reality for more and more families. Over the past three decades, cases of conditions like Stroke, Epilepsy, Migraine, and Dementia have more than doubled. Today, these account for almost 10% of the nation's overall disease burden; Stroke alone took the lives of nearly 7 lakh people in 2019. What's alarming is that stressors we live with daily: high blood pressure, poor diet choices, rising pollution levels, and chronic mental strain are the triggers. A comprehensive study led by the India State-Level Disease Burden Initiative-supported by ICMR, PHFI, IHME, and the Ministry of Health-highlighted these trends and published the findings in The Lancet Global Health. It is wake-up call, our brain health is far more fragile than we realise. That's what makes the Fortis Mumbai campaign so meaningful. By turning helmet into a powerful symbol, and carries a message that's hard to miss: protecting your brain is not just about reacting to emergencies; it's about living more mindfully, every single day. Talking about the initiative, Dr S Narayani, Business Head – Fortis Hospitals, Maharashtra, said, 'At Fortis, our mission goes beyond treating illness, we aim to prevent it through education and awareness. The helmet is a powerful choice for the campaign as it reminds us that just as we protect our head from injury on the roads, we must also protect our brain through awareness, timely action, and healthy choices. For us preventative healthcare is the foundation of a healthy society and through this campaign, we hope to engage the community, and empower them to take proactive steps towards better brain health.' As part of World Brain Day, Fortis Hospitals in Mumbai brought brain health awareness to the forefront with a unique, people-first approach. At all four units-Mulund, Kalyan, Vashi, and Mahim-Patient Care Services staff wore helmets within hospital premises, sparking heartfelt conversations with patients and their families about the importance of brain health. Community sessions hosted at open spaces helped Neurologists share insights on recognizing early warning signs, and stressed the value of timely care. The initiative extended to notable locations across Mumbai, as reactions and real-time moments were shared across Fortis Mumbai's social media pages, helping the message of brain health reach the community at large. 'When it comes to brain health, lifestyle plays a very important role and should not be overlooked. One particular acronym that tell my patients to lookout for is termed SHAAADOWSSS, which stands for Smoking, Hypertension, Age over 60 years, Alcohol Abuse, Atrial fibrillation, Diabetes, Obesity, Wellspring (family history), Stress, Sedentary Lifestyle and Sleep Disorders. True to its name, these conditions follow you around like a shadow and if left unmanaged they significantly increase your risk of developing issues like Stroke. The good news is simple, conscious changes in your daily routine can drastically lower that risk and protect your brain for the long run,' said Dr Ashok Hande, Director – NeuroSurgery, Fortis Hiranandani Hospital, Vashi, while talking about the role lifestyle awareness plays in brain health preservation. Dr Sreelakshmi N. Consultant-Neurology, S.L. Raheja Hospital, Mahim, said, 'Everything you experience flows from the brain. Yet, your brain remains the body's most sensitive organs. Issues like Stroke can appear suddenly, while conditions such as Dementia may develop gradually and quietly. That's why paying attention to even subtle changes matters. Don't ignore the signs your body may be giving you. Acting early can change outcomes.' Highlighting the role family history, Dr Gurneet Singh Sawhney, Director-Stereotaxy and Functional Neurosciences, Fortis Hospital, Mulund said, 'Family history plays a crucial role when managing disease burden. If someone in the patient's family has had ailments like Dementia, Stroke etc. then one's chances of developing neurological complications may be higher. That makes it even more critical to be aware of the warning signs, get regular health check-ups, and adopt a healthy lifestyle to reduce your risk.' DrRushabh Chheda, Consultant, Neurosurgery and Stroke Intervention Specialist, Fortis Hospital Kalyan, said, 'Brain health is too important to take chances with. Any warning sign you observe should be taken as a medical emergency, not be considered a wait-and-watch situation. There is a common saying in Neurology which says – time is brain – thus the quicker you act, the more brain function can be saved and every minute counts when it comes to protecting your brain and your life, so act fast to preserve what matters most.' The message is clear: it's time for Mumbai to act decisively with stronger strategies for prevention, better awareness, and more accessible neurological care-before this silent epidemic grows louder. About Fortis Healthcare Fortis Healthcare Limited – an IHH Healthcare Berhad Company – is a leading integrated healthcare services provider in India. It is one of the largest healthcare organizations in the country with 27 healthcare facilities, ~4,750 operational beds (including O&M facilities), and over 400 diagnostics centers (including JVs). The Company is listed on the BSE Ltd and National Stock Exchange (NSE) of India. It draws strength from its partnership with a global major and parent company – IHH, to build upon its culture of world-class patient care and superlative clinical excellence. Fortis employs over 23,000 people (including Agilus Diagnostics Limited) who share its vision of becoming the world's most trusted healthcare network. Fortis offers a full spectrum of integrated healthcare services ranging from clinics to quaternary care facilities and a wide range of ancillary services.
Hans India
a day ago
- Hans India
Rs 33,081 cr approved to states from FY22 to FY26 to boost health infra: Govt
New Delhi: In a bid to strengthen public health infrastructure, States and Union Territories (UTs) have been approved a total of Rs 33,081.82 crore from FY 2021-22 to FY 2025-26, said Prataprao Jadhav, Union Minister of State for Health and Family Welfare, in the Parliament on Tuesday. In a written reply in the Rajya Sabha, Jadhav highlighted the measures under the Pradhan Mantri Ayushman Bharat Health Infrastructure Mission (PM-ABHIM) to develop capacities of health systems and institutions across primary, secondary, and tertiary levels. Better infrastructure can help prepare health systems to effectively respond to the current and future pandemics or disasters. 'Administrative approvals have been accorded to States/UTs for FY 2021-22, FY 2022-23, FY 2023-24, FY 2024-25, and FY 2025-26 for an amount of Rs 33081.82 Crore,' Jadhav said. The amount has been utilised to construct and strengthen "10,609 building less- Ayushman Arogya Mandirs (AAMs); 5,456 urban AAMs; 2,151 block public health units (BPHUs); 744 integrated public health laboratories (IPHLs) at district level and 621 critical care hospital blocks (CCBs),' the Minister added. PM-ABHIM is a Centrally Sponsored Scheme (CSS) with some Central Sector Components (CS), which has an outlay of Rs. 64,180 Crores for the scheme period (2021-22 to 2025-26). The scheme aims for the construction of 17,788 building-less Sub-Centres as Ayushman Bharat- Health and Wellness centres, now known as AAMs, during the period. Further, it also aims to establish 11,024 health and wellness centres, now known as U-AAMs, in urban areas with a focus on slum and slum like areas; 3,382 BPHUs at the block level; 730 district IPHLs in the country, wherein each district will have one such lab. The funds will also be utilised to establish 602 CCBs in all districts with a population of more than 5 lakhs.
New Indian Express
a day ago
- New Indian Express
AdFalciVax: India's shot at stopping malaria on its tracks
India will soon have an advanced vaccine against malaria. In a major scientific breakthrough, the Indian Council of Medical Research (ICMR) has developed an innovative recombinant, chimeric multi-stage malaria vaccine that could transform malaria prevention and control efforts in India and globally. Named AdFalciVax, the vaccine has been developed to offer both protection against Plasmodium falciparum infection in humans and interruption of community transmission, unlike the existing two vaccines that can partially prevent infection in humans but cannot stop transmission in the community. The novel vaccine developed by Regional Medical Research Centre (RMRC), Bhubaneswar, one of the constituent institutes of ICMR, is now ready for technology transfer to manufacturers or organisations for production, clinical trials and its commercialisation. Preliminary trials on animal models have been highly successful. The pre-clinical validation of the vaccine has been conducted in collaboration with National Institute of Malaria Research (NIMR), another constituent institute of ICMR, and National Institute of Immunology (NII), New Delhi, an autonomous research institute of the Department of Biotechnology, Government of India. A dual-stage game changer Unlike the currently available WHO-recommended vaccines - RTS, S/AS01 (Mosquirix), and R21/Matrix-M which have shown efficacies ranging between 33% and 67%, AdFalciVax promises dual-stage protection. It will not only shield people from contracting the deadliest strain of malaria but also prevent its spread within communities, considered an essential factor in breaking the chain of transmission. Dr Susheel Singh, scientist-D at RMRC, said AdFalciVax deploys a full-length PfCSP (circumsporozoite protein), a key surface antigen of P falciparum, for broader immune protection. It also incorporates a novel fusion of Pfs230 and Pfs48/45 proteins to induce potent transmission-blocking antibodies. 'The new vaccine can prevent human infection and interrupts transmission in the community, thereby tackling two critical developmental bottlenecks in the malaria parasite's life cycle,' Dr Singh said. The RMRC researchers said the vaccine has been developed using advanced protein engineering techniques and it leverages Lactococcus lactis, a safe bacterial host system, for antigen production. Additional director general of ICMR and director of RMRC Dr Sanghamitra Pati said preclinical trials conducted on mice showed robust and long-lasting immunity, even when exposed to 10,000 dual-transgenic Plasmodium berghei parasites engineered to express P falciparum antigens. 'The immune protection lasted over four months post-booster dose, which translates to more than a decade of protection in humans. The vaccine was administered with safe alum-based adjuvants and showed no adverse reactions,' said Dr Pati. Senior scientist Dr Subhash Singh was also a key contributor to the development of the vaccine. High stability at low cost The uniqueness of AdFalciVax over existing vaccines is its pharmaceutical stability. The formulation remains potent for over nine months at room temperature, doing away with the need for expensive cold chain logistics, which continue to be a long-standing challenge in vaccine distribution, especially in remote and under-resourced regions. The vaccine is also highly cost-effective, with an estimated production cost of just `20 per dose. The current vaccines are priced between `250 and `830 per dose. The affordability of the newly developed vaccine could make mass immunisation programmes significantly more viable. ICMR has now invited expressions of interest from eligible firms and manufacturers for technology transfer and commercial-scale production. The vaccine is expected to go for clinical trial stages soon and potentially be rolled out for public use in the next few years. However, the efficacy during the clinical trials will be the key.
